Regulatory Affairs Services Provider in Argentina
DDReg delivers regulatory affairs services in Argentina for pharmaceutical, medical device, biologics, and health product manufacturers. Our team manages ANMAT submissions, clinical trial authorizations, and post-approval compliance across Latin America's third-largest pharmaceutical market.
Expert Regulatory Consulting in Argentina
Argentina represents one of the largest pharmaceutical markets in Latin America. The healthcare sector continues growth driven by demand for advanced therapies and specialty drugs. Foreign manufacturers recognize substantial commercial opportunity in Argentina's market expansion.
Market entry demands precise navigation of Argentina's regulatory framework. The Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) operates as a decentralized authority under the Ministry of Health. ANMAT regulates product registration, quality control, pharmacovigilance, clinical trials, and counterfeit drug prevention. DDReg's pharmaceutical regulatory affairs in Argentina practice provides ANMAT registration services and regulatory support in Argentina from pre-submission strategy through lifecycle compliance.
Argentina Regulatory Authorities
Three primary authorities regulate life sciences products in Argentina:
| Regulatory Body | Jurisdiction |
|---|---|
| ANMAT | Pharmaceuticals, medical devices, cosmetics, food supplements |
| SENASA | Veterinary products, animal nutrition |
| INAL | Nutrition products, labeling, safety evaluation (within ANMAT) |
ANMAT Registration Services Portfolio
DDReg provides comprehensive regulatory affairs services in Argentina across product lifecycle phases:
-
Pharmaceutical Regulatory Affairs Argentina
-
Medical Device Registration
-
Biologics and Biosimilars
-
Cosmetics and Supplements
ANMAT Regulatory Affairs Process
DDReg manages Argentina submissions through structured regulatory phases:
-
Product Classification and Strategy
-
Local Representative Appointment
-
Technical Documentation Preparation
-
GMP Certification Coordination
-
Submission and Review Management
-
Post-Approval Implementation
ANMAT Approval Timelines
Registration timelines vary by product category and submission completeness:
| Product Category | Typical Timeline |
|---|---|
| Generic Pharmaceuticals | 6-9 months |
| Innovative Pharmaceuticals | 12-18 months |
| Vaccines and Biologics | 18-24 months |
| Medical Devices (Class I-II) | 3-6 months |
| Medical Devices (Class III-IV) | 6-12 months |
| Cosmetics (Grade 1) | 1-2 months |
| Cosmetics (Grade 2) | 4-8 months |
Note: Incomplete Spanish translations or delayed GMP certification extend these timelines substantially.
DDReg's Argentina Regulatory Expertise
Our consultants understand ANMAT's Argentina-specific dossier requirements, GDE submission protocols, and review evaluation standards. This knowledge shapes documentation strategies and regulatory pathway selection.
DDReg employs Argentine Spanish-fluent regulatory specialists who ensure technical terminology accuracy in translations. This prevents misinterpretation during ANMAT review and reduces deficiency likelihood.
Our Argentina partner network facilitates MAH designation for foreign manufacturers without local presence. This enables market access without establishing Argentine legal entities.
DDReg prepares audit-ready GMP documentation, coordinates ANMAT site inspections, and manages FDA/EMA certificate recognition procedures. Our systems ensure manufacturing compliance verification meets ANMAT standards.
Argentina participates in MERCOSUR regulatory cooperation frameworks. DDReg leverages harmonization initiatives for cosmetics, medical devices, and certain pharmaceutical categories when advantageous for multi-country registrations.
Global Reach Explorer
Find Your Solution
Our Regulatory Affairs Consulting Services in Argentina portfolio covers:
Regulatory Strategies
The pharmaceutical industry operates under stringent regulations to ensure the safety, efficacy, and quality...
New Product Marketing Authorizations
Navigating marketing authorization is a complex and time-sensitive process. Every country has its own regulatory framework...
Gap Analysis and Remediation
In the highly regulated pharmaceutical industry, maintaining compliance is critical. Regulatory gap analysis helps identify deficiencies in technical documentation...
Regulatory Due Diligence
Regulatory issues arise unexpectedly and can create significant strain on a company’s resources. As such, it is advisable for all companies to carry out regular and frequent regulatory due diligence and audits...
API & DMF services
Drug Master Files (DMFs) contain confidential and detailed information regarding API processes—from manufacturing to storage. DDReg’s DMF Services deliver precise...
CMC Advisory
DDReg’s CMC services are dedicated to assisting customers in developing robust and an efficient regulatory strategy through all development phases - authoring...
Post Approval Life Cycle Management
Maximize product value with expert pharma lifecycle management. Our dedicated team ensures that your product remains on shelves and compliant with ever-evolving regulations through strategic post-approval management...
Certification Services
Partner with DDReg to navigate the complex process of regulatory certification of pharmaceutical...
ANDA and MA Holder Services
Our comprehensive services support both Abbreviated New Drug Applications (ANDA) and Marketing Authorization processes.
Publishing & Submission
Our comprehensive digital solution transforms traditional paper dossier submissions into a streamlined electronic format. With robust infrastructure and cutting‐edge management processes...
